Malnutrition and malaria treatment
We will continue to evaluate the pharmacokinetic and pharmacodynamic properties of antimalarial drugs in malnourished children, and use modelling and simulation to suggest revised dose regimens. The collaboration with the MSF-site in Niger will continue to gather data in this particularly vulnerable group of patients.